Spark submission brings first gene therapy for genetic disease closer – The Pharma Letter (registration)
Spark submission brings first gene therapy for genetic disease closerThe Pharma Letter (registration)US biotech firm Spark Therapeutics (Nasdaq: ONCE) has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for … Continue reading
